These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18049924)

  • 21. Continuing increases in autism reported to California's developmental services system: mercury in retrograde.
    Schechter R; Grether JK
    Arch Gen Psychiatry; 2008 Jan; 65(1):19-24. PubMed ID: 18180424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From the Centers for Disease Control and Prevention. Recommendations regarding the use of vaccines that contain thimerosal as a preservative.
    JAMA; 1999 Dec; 282(22):2114-5. PubMed ID: 10591323
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccines and autism: evidence does not support a causal association.
    DeStefano F
    Clin Pharmacol Ther; 2007 Dec; 82(6):756-9. PubMed ID: 17928818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mercury, vaccines, and autism: one controversy, three histories.
    Baker JP
    Am J Public Health; 2008 Feb; 98(2):244-53. PubMed ID: 18172138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thimerosal in vaccines--An interim report to clinicians. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Environmental Health.
    Pediatrics; 1999 Sep; 104(3 Pt 1):570-4. PubMed ID: 10469789
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells is inhibited by the ethylmercury-containing preservative thimerosal.
    Mutkus L; Aschner JL; Syversen T; Shanker G; Sonnewald U; Aschner M
    Biol Trace Elem Res; 2005; 105(1-3):71-86. PubMed ID: 16034155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mercury in vaccines may not pose harm.
    Child Health Alert; 2003 Jan; 21():1. PubMed ID: 12608349
    [No Abstract]   [Full Text] [Related]  

  • 28. Immuno-biochemical evaluations of phenol and thimerosal as antigen preservatives in Montenegro skin test.
    Mayrink W; Coelho GL; Guimarães TM; de Andrade HM; de Castro Peres E; da Costa CA; de Toledo Vde P
    Acta Trop; 2006 Apr; 98(1):87-93. PubMed ID: 16527224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine adverse events: separating myth from reality.
    Kimmel SR
    Am Fam Physician; 2002 Dec; 66(11):2113-20. PubMed ID: 12484693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products.
    Magos L
    J Appl Toxicol; 2001; 21(1):1-5. PubMed ID: 11180274
    [No Abstract]   [Full Text] [Related]  

  • 31. Being on the track of thimerosal. Review.
    Mádi A
    Acta Microbiol Immunol Hung; 2005; 52(1):95-103. PubMed ID: 15957237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What happened to primum non nocere?
    Seal JB; Daum RS
    Pediatrics; 2001 May; 107(5):1177-8. PubMed ID: 11331704
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
    Geier DA; Geier MR
    Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of organic and inorganic mercury distribution in suckling rat.
    Orct T; Blanusa M; Lazarus M; Varnai VM; Kostial K
    J Appl Toxicol; 2006; 26(6):536-9. PubMed ID: 17080402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thimerosal is unrelated to autoimmune autism.
    Singh VK
    Pediatr Allergy Immunol; 2007 Feb; 18(1):89. PubMed ID: 17295806
    [No Abstract]   [Full Text] [Related]  

  • 36. Hair mercury in breast-fed infants exposed to thimerosal-preserved vaccines.
    Marques RC; Dórea JG; Fonseca MF; Bastos WR; Malm O
    Eur J Pediatr; 2007 Sep; 166(9):935-41. PubMed ID: 17237965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.
    Dórea JG
    Clin Chim Acta; 2010 Nov; 411(21-22):1580-6. PubMed ID: 20638374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
    Geier D; Geier MR
    Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J; Golding J;
    Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiomersal in vaccines: is removal warranted?
    Clements CJ; Ball LK; Ball R; Pratt RD
    Drug Saf; 2001; 24(8):567-74. PubMed ID: 11480489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.